AngioDynamics, Inc.
ANGO
$9.22
$0.111.21%
NASDAQ
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.76% | -12.56% | -13.06% | -12.85% | -10.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.76% | -12.56% | -13.06% | -12.85% | -10.28% |
| Cost of Revenue | -9.67% | -19.91% | -16.54% | -13.75% | -9.29% |
| Gross Profit | 1.94% | -5.25% | -9.68% | -12.00% | -11.22% |
| SG&A Expenses | 0.99% | -1.21% | -0.05% | -2.36% | -0.19% |
| Depreciation & Amortization | -20.92% | -30.75% | -32.69% | -31.77% | -30.56% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.28% | -12.67% | -10.19% | -8.76% | -5.50% |
| Operating Income | 28.90% | 13.89% | -28.85% | -57.06% | -81.19% |
| Income Before Tax | 82.24% | 78.90% | -2,456.47% | -4,081.92% | -252.04% |
| Income Tax Expenses | 99.46% | 90.41% | -362.38% | 131.79% | -265.36% |
| Earnings from Continuing Operations | 81.56% | 78.48% | -1,491.96% | -3,870.26% | -251.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.56% | 78.48% | -1,491.96% | -3,870.26% | -251.53% |
| EBIT | 28.90% | 13.89% | -28.85% | -57.06% | -81.19% |
| EBITDA | 80.52% | 8.19% | -222.55% | -182.39% | -169.97% |
| EPS Basic | 81.78% | 78.70% | -1,480.95% | -4,004.14% | -244.11% |
| Normalized Basic EPS | 45.99% | 37.48% | -15.26% | -29.87% | -48.01% |
| EPS Diluted | 81.71% | 78.60% | -1,476.04% | -4,050.13% | -244.82% |
| Normalized Diluted EPS | 45.93% | 37.41% | -15.41% | -30.05% | -47.87% |
| Average Basic Shares Outstanding | 1.67% | 1.85% | 1.92% | 1.95% | 1.78% |
| Average Diluted Shares Outstanding | 1.59% | 1.77% | 1.84% | 1.87% | 1.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |